[5] Graves disease is an autoimmune thyroid disorder characterized by excessive thyroid hormone production (hyperthyroidism) due to thyroid-stimulating immunoglobulins that activate the thyroid-stimulating hormone (TSH) receptor
Noticeable results often appear after a few weeks of regular use
M., Moroan, E., Dumitrescu, D.-E., Roca, A
They have demonstrated a consistent reduction in the risk of mortality in patients with T2D and established heart disease, and in patients with HF with reduced ejection fraction (HFrEF)
10.1016/j.clnu.2011.10.005 20 MadsenJ
In terms of the known consequences of the neurostimulatory actions of the GLP-1 agonist on GI function, GLP-1 suppresses GI contractile activity (Schirra et al., 2006